Biglycan, a vascular proteoglycan, binds differently to HDL2 and HDL3: Role of apoE

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 1, 2001, Pages 129-135

  Olin, Katherine L ^a   Potter Perigo, Susan ^a   Barrett, P Hugh R ^b   Wight, Thomas N ^a   Chait, Alan ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Apolipoprotein E; Atherosclerosis; Biglycan; High density lipoproteins; Proteoglycans

Indexed keywords

APOLIPOPROTEIN E; BIGLYCAN; HIGH DENSITY LIPOPROTEIN; PROTEOGLYCAN;

ACETYLATION; ARTICLE; ATHEROSCLEROSIS; CHEMICAL MODIFICATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; RECEPTOR BINDING; VASCULAR ENDOTHELIUM;

EID: 0035173410     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.1.129     Document Type: Article

References (46)

1. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: Its possible role in atherogenesis
2. The response-to-retention hypothesis of early atherogenesis
3. Arterial wall proteoglycans: Biologic properties related to the pathogenesis of atherosclerosis
4. Identification of apo B-100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans
5. Molecular basis of the association of arterial proteoglycans with low density lipoproteins: Its effect on the structure of the lipoprotein particle
6. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries
7. Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries
8. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: Co-localization of biglycan with apolipoproteins
9. Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/ biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture
10. Platelet derived growth factor and transforming growth factor-β1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells
11. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry
12. Proteoglycans in human coronary arteriosclerotic lesions
13. Prominence of apolipoproteins B, (a), and E in the intimae of coronary arteries in transplanted human hearts: Geographic relationship to vessel wail proteoglycans
14. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
15. Apolipoprotein E: From atherosclerosis to Alzheimer's disease and beyond
16. Apolipoprotein localization in human cranial arteries, coronary arteries, and the aorta
17. Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries
18. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-1 in the human artery wall with the progression of atherosclerosis
19. Immunohistochemical localization of apolipoproteins A-I and B in human carotid arteries
20. Immunolocalization of high-density lipoproteins in arterial walls of rats
21. Co-localization of serum amyloid A with apolipoprotein A-I and perlecan in lesions of atherosclerosis-prone mice
22. Fish apolipoprotein-A-I has heparin binding activity: Implication for nerve regeneration
23. Superoxide-mediated free radical modification of low density lipoprotein by arterial smooth muscle cells
24. Protein measurement with the Folin phenol reagent
25. Apolipoprotein E mediates uptake of Sf 100-400 hyperi triglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts
26. Lipoprotein-receptor interactions
27. Pathophysiological concentrations of glucose promote oxidative modification of LDL by superoxide-dependent pathway
28. 2-chloride system of phagocytes, covalently modifies epsilon-amino groups of protein lysine residues
29. Lipoprotein lipase enhances the binding of native oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells
30. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue
31. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells
32. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues
33. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells
34. Measurements of proteoglycan-lipoprotein interaction by gel mobility shift assay
35. milano: Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I
36. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid
37. Rate and equilibrium constants for binding of apo-E HDLc (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: Evidence for multiple receptor binding of apo-E HDLc
38. Cell surface receptor binding of phospholipid protein complexes containing different ratios of receptor-active and -inactive E apoprotein
39. Identification of the principal proteoglycan-binding site in LDL: A single point mutation in apolipoprotein B100 severely affects proteoglycan interaction without affecting LDL receptor binding
40. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease
41. High-density lipoprotein subfractions
42. Metabolism of high density lipoprotein subfractions
43. Apolipoprotein E secretion by macrophages: Its potential physiological functions
44. Endogenous apoE expression modulates HDL3 binding to macrophages
45. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells
46. In vitro oxidised HDL is recognized by the scavenger receptor of macrophages: Implications for its protective role in vivo